FeesSafety
Pluang+

Sharplink reports 24% revenue growth and $751M net income in Q3 2026, driven by Ethereum treasury strategy.

Company Fundamentals
09 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
Sharplink reports 24% revenue growth and $751M net income in Q3 2026, driven by Ethereum treasury strategy.

Sharplink, a major corporate holder of Ether (ETH), reported a 24% year-over-year revenue increase to $13.5 million and a net income of $751.4 million for Q3 2026, largely due to gains on crypto assets and effective ETH treasury management. The company completed a $200 million ETH staking allocation and launched the Galaxy Sharplink Onchain Yield Fund to enhance yield opportunities. Sharplink's strategy focuses on treating ETH as a productive asset, supporting Ethereum's growing institutional adoption and aiming to create long-term shareholder value. The company holds approximately 892,708 ETH and is positioned to benefit from Ethereum's expanding role in global finance.

Sharplink's Q3 2026 financial results provide context for readers interested in corporate crypto holdings. For readers following US stocks on Pluang, here is the market snapshot as of Nov 09, 2026 19:51 WIB: out of 150 priced US stocks, 115 rose and 33 fell today. Notable movers include BHP Billiton Limited (BHP) at USD 82.69 with a 3.50% increase, Barclays PLC (BCS) at USD 23.04 up 3.18%, and Carnival Corp (CCL) at USD 30.51 rising 3.14%.

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
1 hour ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
2 hours ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
2 hours ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
2 hours ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App